ArticleExperimental brain research2026

Rosiglitazone alleviates white matter injury by inhibiting NLRP3/capspase-1 mediated microglial pyroptosis via downregulating KLF4.

Liufang He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.